Halozyme Acquires Antares Pharma 2022 Investor Conference

Halozyme Therapeutics announced the acquisition of Antares Pharma on April 13, 2022, presented during an investor conference call. The presentation outlines the proposed merger, including regulatory considerations, integration plans, and forward-looking financial projections for the combined entity.